Author

Akshara Narayanan

University of Glasgow

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Binghua Zhang· 1 shared Elżbieta KaniaiD· 1 shared Evie RigbyiD· 1 shared Fengtao ZhouiD· 1 shared Francesca Fasanella MasciiD· 1 shared Jamie J.L. WilliamsiD· 1 shared John A. HarrisiD· 1 shared Karen KeeshaniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Binghua Zhang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inducing TRIB2 Targeted Protein Degradation to Reverse Chemoresistance in Acute Myeloid Leukemia

Evie Rigby, Francesca Fasanella Masci, Akshara Narayanan, Elżbieta Kania, John A. Harris, Jamie J.L. Williams, Binghua Zhang, Lijun Liu, Laura Richmond, Fengtao Zhou, Ke Ding, Ruaidhrı́ J. Carmody, Patrick A. Eyers, Karen Keeshan

This study identifies TRIB2 as a therapeutic target in AML by demonstrating that its degradation via PROTACs and small molecules can reverse chemoresistance and enhance chemotherapy efficacy.

Biochemical Journal · Mar 13, 2026Peer-reviewedCancer Biology